MAP3K7 and autoimmune hepatitis: The findings from the current study suggest that TAK1 may mediate the development of AIH through its phosphorylation and activation of iκB‐α degradation, as well as miRNA‐143 may prevent TAK1‐medicated events in AIH mice.